Narlumosbart
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Narlumosbart, covering 2024-03-18 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer [Phase 2]